Literature DB >> 11167547

Genosubtyping by sequencing group A, B and C meningococci; a tool for epidemiological studies of epidemics, clusters and sporadic cases.

P Mölling1, M Unemo, A Bäckman, P Olcén.   

Abstract

Genosubtyping, by sequencing variable regions (VRs) 1, 2 and 3 of the porA gene, was evaluated as a tool to detect clonality of isolates in meningococcal epidemics in Africa and clusters of disease in Sweden. All 63 examined meningococcal isolates were successfully genosubtyped. The isolates belonging to group A type 4 with genosubtype P1.20,9,35a showed little heterogeneity in African epidemics in 1988 and onwards. In Sweden, two meningococcal clones of group B type 15, with genosubtypes P1.7,16,35 and P1.7,16f,35, dominated during two clusters of meningococcal disease in 1995-96 and in sporadic cases thereafter. The characterisation of group C meningococci isolated during 1992 in Sweden indicated a cluster (type 2a with genosubtype P1.5a,10d,36b) connected with a discotheque visit. Two variants of VR2 (10p and 25b), not previously described, were found among the examined isolates. Nucleotide sequence analysis of VRs in the porA gene proved a valuable epidemiological tool since almost all isolates could be genosubtyped, in contrast to the phenotypic methods presently used.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11167547

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  9 in total

1.  Comparison of serogroup W-135 meningococci isolated in Sweden during a 23-year period and those associated with a recent hajj pilgrimage.

Authors:  P Mölling; A Bäckman; P Olcén; H Fredlund
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

2.  Direct and rapid identification and genogrouping of meningococci and porA amplification by LightCycler PCR.

Authors:  Paula Mölling; Susanne Jacobsson; Anders Bäckman; Per Olcén
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

3.  First report of capsule replacement among electrophoretic type 37 Neisseria meningitidis strains in Italy.

Authors:  Paola Stefanelli; Cecilia Fazio; Arianna Neri; Tonino Sofia; Paola Mastrantonio
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

4.  PorA variable antigenic regions VR1, VR2, and VR3 of Neisseria meningitidis serogroups B and C isolated in Brazil from 1999 to 2004.

Authors:  Ivano de Filippis; Claudia Ferreira de Andrade; Luciete Silva; D Rebecca Prevots; Ana Carolina P Vicente
Journal:  Infect Immun       Date:  2007-05-14       Impact factor: 3.441

5.  Molecular and serological diversity of Neisseria meningitidis carrier strains isolated from Italian students aged 14 to 22 years.

Authors:  Roberto Gasparini; Maurizio Comanducci; Daniela Amicizia; Filippo Ansaldi; Paola Canepa; Andrea Orsi; Giancarlo Icardi; Emanuela Rizzitelli; Gabriella De Angelis; Stefania Bambini; Monica Moschioni; Sara Comandi; Isabella Simmini; Giueseppe Boccadifuoco; Brunella Brunelli; Marzia Monica Giuliani; Mariagrazia Pizza; Donatella Panatto
Journal:  J Clin Microbiol       Date:  2014-03-19       Impact factor: 5.948

6.  Long-term predominance of a rare meningococcal phenotype in a small geographical area.

Authors:  P Stefanelli; C Fazio; A Neri; T Sofia; P Kreidl; S Salmaso; P Mastrantonio
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-08-21       Impact factor: 3.267

7.  Serogroup C meningococci in Italy in the era of conjugate menC vaccination.

Authors:  Paola Stefanelli; Cecilia Fazio; Tonino Sofia; Arianna Neri; Paola Mastrantonio
Journal:  BMC Infect Dis       Date:  2009-08-22       Impact factor: 3.090

8.  Sequential analysis of biomarkers in cerebrospinal fluid and serum during invasive meningococcal disease.

Authors:  O Beran; D A Lawrence; N Andersen; O Dzupova; J Kalmusova; M Musilek; M Holub
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-02-10       Impact factor: 3.267

9.  Diversity of Greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine.

Authors:  Georgina Tzanakaki; Eva Hong; Konstatinos Kesanopoulos; Athanasia Xirogianni; Stefania Bambini; Luca Orlandi; Maurizio Comanducci; Alessandro Muzzi; Muhamed-Kheir Taha
Journal:  BMC Microbiol       Date:  2014-04-29       Impact factor: 3.605

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.